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Planning endovascular vein valve implantation:
Significance of vein size variability
Sergio X. Salles-Cunha, PhD, RVT, Susan Shuman, RN, and Hugh G. Beebe, MD, Toledo, Ohio
Objective: Endovascular placement of prosthetic valves is currently in clinical trials as treatment for lower extremity venous
hypertension caused by valvular insufficiency. Femoropopliteal vein sizing is a critical factor in treatment planning. A
wide diameter range could influence selection of an endoprosthesis. Quantitative data describing intrasubject vein
diameter variation are scant. We measured vein diameters with ultrasound imaging to assess minimum-maximum
diameter range under forced conditions of venoconstriction and venodilatation.
Methods: Diameter of the common femoral vein (CFV), proximal femoral vein (PFV), mid-femoral vein (MFV), and distal
femoral vein (DFV) in the thigh and the popliteal vein (PV) was measured in the morning under conditions of minimal
venodilation and in the afternoon under conditions of stressed venodilatation that included activities of daily living and
a 5-minute treadmill walk. Measurements were obtained twice on two different days in both extremities in 20 subjects
with CEAP clinical classification C0 (n  10), C3 (n  7), C4 (n  1), or C5 (n  2).
Results: Average vein diameter increased, from 11.2  2.5 (SD) mm to 14.5  2.3 mm at the CFV, from 6.9  1.8 mm
to 9.4  1.9 mm at the PFV, from 6.9  1.6 mm to 9.0  1.8 mm at the MFV, from 7.3  1.7 mm to 9.1  1.5 mm at
the DFV, and from 8.4  1.4 mm to 9.7  1.8 mm at the PV (P < .001 for all differences). Maximum diameter change
was 8.2 mm at the CFV, 7.0 mm at the PFV, 6.6 mm at the MFV, 6.0 mm at the DFV, and 5.1 mm at the PV. Dilatation
of 4 mm or greater occurred in 43% of CFV, 15% of PFV, 11% of MFV, 3% of DFV, and 1% of PV. Minimum vein diameter
was found at PFV in 41%, MFV in 34%, and DFV in 23% of morning measurements and at PFV in 21%, MFV in 38%, DFV
in 28%, and PV in 16% of afternoon measurements.
Conclusions: Femoropopliteal veins demonstrated a wide range of diameters, and significant diameter changes were
detected in all vein segments. Variations in vein diameter must be evaluated in candidates for endovascular venous valve
prostheses. Such devices must adapt to a wide range in vein diameter. (J Vasc Surg 2003;37:984-90.)
Endovascular placement of a prosthetic valve is an
investigational alternative for treatment of chronic venous
insufficiency in the lower extremities. We participated in
clinical trials to evaluate the safety and efficacy of biopros-
thetic valves developed primarily to treat deep vein insuffi-
ciency in patients with healed or nonhealed ulcers. The
venous valve prosthesis was available in diameters that
differed by 2 mm. Sizing the femoral vein for device selec-
tion and endovascular positioning therefore was critical in
treatment planning.
Change in femoropopliteal vein diameter has been
described,1-7 and we have observed anecdotally that varia-
tions in vein size and shape occur as a function of multiple
environmental conditions and patient status. Therefore we
sought to measure lower extremity vein diameter under
conditions likely to produce a minimal diameter (venocon-
striction) or maximal diameter (venodilatation) at different
times of the day. This minimum-maximum diameter range
could influence prosthesis selection. We tested the null
hypothesis that there was no significant difference in the
diameter of common femoral, femoral, and popliteal veins
under conditions of venoconstriction versus venodilata-
tion.
METHODS
Ultrasound B-mode imaging of femoropopliteal veins
was performed in the morning and afternoon of two sepa-
rate days, with defined conditions expected to minimize
vein diameter in the morning and to dilate veins in the
afternoon. Vein diameter was measured in five locations:
common femoral vein (CFV), proximal femoral vein
(PFV), mid-femoral vein (MFV), and distal femoral vein
(DFV) in the thigh, and popliteal vein (PV). For each
location, three ultrasound scans showing the vein in trans-
verse section were obtained, and diameters were measured
in vertical and horizontal directions. The vertical direction
was approximately anteromedial to posterolateral in the
femoral segments, and posteroanterior in the popliteal seg-
ment.
Subject population. The study focused on determin-
ing diameter variations and ranges for femoropopliteal vein
segments. Subject sample population represented a wide
spectrum of normal and diseased veins. A specific, limited
subject population was avoided. Twenty subjects were en-
tered in the study and grouped according to recommended
CEAP classification guidelines.8,9 Ten patients had no
symptoms (class C0); 7 had edema (C3), 1 had skin changes
(C4), and 2 had healed venous ulcers (C5). One C5 patient
had unilateral postthrombotic venous obstruction; the
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other had bilateral primary deep and superficial venous
insufficiency. The C4 patient had primary valvular insuffi-
ciency without varices and lymphedema. Two C3 patients
had unilateral postthrombotic syndrome, 2 had valvular
insufficiency of superficial veins, and 3 had deep vein insuf-
ficiency. Subjects were selected to provide equal gender
representation and a wide age distribution. For class C0, 1
woman and 1 man each in the third (20-29 years), fourth,
fifth, sixth, and seventh decade of life were entered in the
study. Average age for this group was 46  16 (SD) years
(range, 27-69 years). For classes C3-5, 2 subjects each in the
fifth (40-49 years) and sixth decade of life, and 3 subjects
each in the seventh and eighth decade of life were entered.
Average age for this group was 61 11 years (range, 45-74
years). One subject was excluded from the study because of
a duplicate femoral vein.
Morning measurements. Morning examinations
were performed at about 8:00 AM. Conditions were created
favoring venoconstriction by asking subjects to abstain
from eating or drinking during the preceding 12 hours and
by performing ultrasound scanning with subjects supine in
a cool but comfortable room. The examining table was
tilted, 10 to 20 degrees feet down, to cause venous filling.
Room temperature averaged 21.9° C  1.2° C. Average
temperature for both right and left great toes measured at
the beginning and end of the test was 24.9° C  2.8° C.
Afternoon measurements. Afternoon examinations
were performed at about 4:30 PM. Conditions were created
favoring venodilatation. Subjects were asked to have an
active day and to drink extra fluids without restriction.
Immediately before the ultrasound examination, subjects
walked for 5 minutes on a treadmill. Velocity and incline
were individually selected to fit each subject’s usual walking
capacity. Ultrasound scanning was performed with subjects
standing in a warm but comfortable room. Room temper-
ature averaged 26.3° C  2.3° C, significantly higher than
during the morning tests (P .001). Average temperature
for both right and left great toes measured at the beginning
and end of the test was 29.4° C  2.4° C, significantly
higher than toe temperatures measured during morning
examinations (P  .001).
Ultrasound diameter measurements. Ultrasound
scanning was performed by a registered vascular technolo-
gist in an ICAVL-accredited vascular laboratory. Images
were obtained with a 4 to 7 MHz linear probe and an ATL
5000 scanner (Philips, Bothel, Wash). During morning
examinations, subjects were supine, with the leg externally
rotated to expose the anteromedial aspect of the thigh. This
position often minimized depth, or distance between the
ultrasound probe and femoral vessels. No change in body
position was required to examine the popliteal vein. During
the afternoon examinations, the subject stood on the floor
with the leg externally rotated.
The CFV was examined below the common femoral
artery bifurcation. The region of the saphenofemoral junc-
tion was avoided. The femoral vein was examined 3 to 5 cm
distal to the confluence with the DFV, at mid-thigh, and
just proximal to the adductor canal. The above-knee pop-
liteal vein was scanned, avoiding geniculate tributaries and
the lesser saphenous vein junction. Regions of valve sinuses
were avoided in all measurements.
A B-mode image colorized with an orange tone was
preferred to enhance venous wall visualization. Edge en-
hancement was also used.
Statistical analysis. Primary statistical analysis was
performed with the paired t test to test the null hypothesis
that there was no significant difference in the diameter of
the CFV, femoral, and PV under conditions of venocon-
striction versus venodilatation. Comparison was made sep-
arately for each of the five vein locations examined, ie, CFV,
PFV, MFV, DFV, and PV. Each pair of measurements
consisted of the average of 6 morning measurements and
the average of 6 afternoon measurements. Because two legs
of 20 subjects were tested on two distinct days, the total
number of measurement pairs compared was 80. In toto,
4800 diameter measurements were entered in the analysis
(6 per location  5 locations  2 legs  2 times a day  2
days  20 subjects).
The range and distribution of morning diameters and
diameter changes were evaluated. Maximum diameter dila-
tation and percentages of veins dilated less than 2 mm, 2 to
less than 4 mm, or 4 mm or more were calculated for all five
locations.
Secondary statistical analysis was performed as follows.
First, location of minimum diameter was determined for
morning and afternoon measurements; the percentage that
each location was a site of minimum diameter was calcu-
lated. Second, variability or uniformity of the six measure-
ments obtained per test was quantified by calculating the
coefficient of variance as the ratio between standard devia-
tion and average.
RESULTS
Average morning and afternoon measurements are
shown in the Table. Diameter was significantly greater in
the afternoon than in the morning for all vein segments
studied (P  .001). Therefore the null hypothesis was
rejected. On average, the PFV dilated the most (36% in-
crease in diameter), followed by the MFV (30%), CFV
(29%), DFV (25%), and PV (15%). Maximum percent
dilatation was 101% for the CFV, 155% for the PFV, 103%
for the MFV, 118% for the DFV, and 66% for the PV.
Distributions of morning diameter and differences detected
for the CFV individually and for the PFV and MFV jointly
are shown in Figs 1 and 2, respectively. Percentage of vein
diameter increase for each location is shown in Fig 3.
The following results were obtained at secondary sta-
tistical analysis. For morning measurements, minimum vein
diameter was found at the PFV in 33 (41%) measurements,
MFV in 27 (34%), DFV in 18 (23%), PV in 1 (1%), and
CFV in 1 (1%); and for afternoon measurements, minimum
vein diameter was found at the PFV in 17 (21%) measure-
ments, MFV in 30 (38%), DFV in 22 (28%), PV in 13
(16%), and CFV in 0 (0%). The coefficient of variability
averaged 7.6%, with a minimum of 6.1% for CFV diameter
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measurements obtained in the afternoon and a maximum
of 8.8% for MFV measurements obtained in the morning.
DISCUSSION
With the advent of endovascular methods for treating
chronic venous insufficiency,10-14 accurate measurement
and understanding of vein diameter change has become
critically important. Presently, a prosthetic venous valve
must be chosen from sizes that differ by 2 mm in diameter.
Implantation site and device selection require information
about venous diameter and range of size variation. There-
fore, we investigated diameter changes in femoropopliteal
veins under conditions likely to stimulate venous constric-
tion or dilatation during normal daily living. Toe tempera-
ture was significantly different between morning and after-
noon, suggesting that measurements were obtained during
two distinct conditions of the peripheral circulation.
The femoral vein dilated approximately 30%, with an
average change of about 2 mm, which might suggest that
the valve device could be selected on the basis of results of
a single ultrasound test performed at any time during the
day. This approach, however, may not be adequate in
certain patients. About a third to a half of patients had
femoral vein changes greater than 2 mm, and the number of
patients with dilatation greater than 4 mm was small but
significant enough to not be ignored. Therefore patients
with a propensity for large changes in venous diameter must
be identified. Such diameter changes must be considered,
not only in selection of a device of appropriate size but also
in the manufacture and testing of prosthetic devices.
The finding that the femoropopliteal vein segment has
a site of minimum diameter and that this site may vary
according to degree of venodilatation raises several topics
for discussion. Implanted prosthetic valves are expected to
appose the vein wall and not migrate; however, if vein wall
contact is lost, proximal or distal migration can occur. Our
data suggest that the femoral vein can be smaller than both
the PV and the CFV. Therefore placement of a valve
endoprosthesis above or below the location of minimum
diameter could assure protection against migration, at least
in one direction. Furthermore, once the valve is in place the
valve site may have the minimum or maximum diameter,
depending on conditions of venous collapse or venous
dilatation. Prosthesis performance should be tested under
these variable conditions.
Another potential implication of diameter change is
related to venous hemodynamics. With air plethysmogra-
phy, significant deterioration was demonstrated in venous
filling index from morning to late afternoon.15 Specifically,
venous filling time after shifting from the supine to the
standing position was shorter in the afternoon. In one fifth
of patients, values that were normal in the morning were
abnormal in the afternoon. This finding correlates with
patient complaints that symptoms occur at the end of the
day. Furthermore, a valve may be competent if the vein is
constricted, and incompetent if the vein is dilated. Patients
with mild or even moderate valvular insufficiency may
benefit if reflux evaluation is performed under conditions
that alter venous diameter.
This subject population, although representative of
gender, age, and mild venous disease, may not represent
vein diameter and vein dilatation capability in patients with
severe deep vein valvular insufficiency. It is probable that
patients with disease caused by deep vein insufficiency have
larger veins than those in the patients included in this series.
Published data suggest that patients with varicose veins
have larger CFV and PFV compared with subjects with
normal veins, probably related to genetic factors.3 Larger
veins may distend more, but may also lose elasticity and fail
to distend over a wide range. Vein size and dilatation may
be affected by previous deep venous thrombosis, a condi-
tion that may result in small vein diameter and minimal
dilatation.16-18 Women may have smaller veins than men,
but differences may eventually disappear as disease
progresses, because gender is no longer a factor when vein
diameter is corrected for body mass.3,6 Age may affect vein
diameter and valve function. Fronek et al2 documented
decreasing CFV diameter with advancing age, especially in
subjects older than 70 years.
This study focused on potential diameter changes that
could be detected in clinical practice. Study of a specific
population was avoided; thus chances of detecting large
diameter changes increased. Additional studies in specific
populations may expand knowledge about variables such as
diameter change as a function of size, deep or superficial
valvular insufficiency, and venous obstruction; however,
evaluation in the clinical setting of valve transplantation
must focus on each individual patient. This investigation
documented diameter changes of 2 mm, 2 to less than 4
mm, and 4 mm or more. Candidates for venous endopros-
theses who have changes in vein diameter large enough to
potentially affect results must be identified. These patients
may be in the minority, but appropriate vein sizing with
evaluation of diameter range is desirable in all cases. Fur-
thermore, it is recommended that bench testing of venous
endoprostheses include diameter changes of the magnitude
described herein.
This study may have been influenced by uncontrolled
technical factors. Vein cross-sectional shape may change
during various activities.1 In this study, veins were circular,
and no apparent differences were noted between vertical
Table I. Diameter measurements in femoropopliteal
venous segments
Vein
Morning veno-
constriction
(mm)
Afternoon
veno-
dilatation
(mm)
Difference
(mm)
Common femoral 11.2  2.5 14.5  2.3 3.3  2.0 (8.2)
Proximal femoral 6.9  1.8 9.4  1.9 2.5  1.6 (7.0)
Mid-femoral 6.9  1.6 9.0  1.8 2.1  1.7 (6.6)
Distal femoral 7.3  1.7 9.1  1.5 1.8  1.3 (6.0)
Popliteal 8.4  1.4 9.7  1.8 1.3  1.4 (5.1)
Values represent mean  SD. Maximum values in parenthesis.
P  .001 for all differences.
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Fig 1. A, Distribution of baseline minimum vein diameter in the common femoral vein (CFV) measured under
conditions of venoconstriction. B, Distribution of baseline minimum vein diameters in the proximal femoral vein (PVF)
and mid-femoral vein (MFV) measured under conditions of venoconstriction.
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Fig 2. A, Distribution of common femoral vein (CFV) diameter changes between maximum and minimum measure-
ments obtained under conditions of venodilatation and venoconstriction, respectively. B, Distribution of proximal
femoral vein (PFV) and mid-femoral vein (MFV) diameter changes between maximum and minimum measurements
obtained under conditions of venodilatation and venoconstriction, respectively.
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and horizontal diameters. During a vein sizing test, condi-
tions that cause veins to fold or to distend abnormally
should be avoided. Measurements at or near valve sites
should be avoided. In rare segments with multiple vein
sinuses this task is difficult, and diameter estimates may be
inconsistent. A longitudinal view of the segment studied,
particularly an ultrasonographic expanded field of view
image 10 to 20 cm long, may clarify the influence of vein
sinuses on diameter measurement. Evaluation in patients
with duplicate veins complicates the issues in discussion.19
About 16% of legs evaluated may have duplicate veins, with
either short or long segments. The subject excluded from
this study had an uneven double vein system, with one
branch larger in the morning and the other branch larger in
the afternoon. The vascular technologist should also im-
prove contrast between vein lumen and vein wall. Although
resolution of ultrasound frequency is sub-millimetric, selec-
tion of lumen-wall interface adds to measurement uncer-
tainty. In practice, the coefficient of variance obtained
indicates that most measurements at one site should be
within 1 to 1.5 mm of each other. These data also suggest
that availability of prostheses differing in size by 2 mm is
adequate.
Patients who potentially could have large diameter
variations under distinct conditions of venoconstriction or
venodilatation must be identified during the process to
select an endoprosthesis. In this study, factors such as time
of day, hydration, posture, daily activities, and exercise were
used to influence vein diameter. Our objective was to
change vein diameter as much as feasibly possible between
two distinct measurements. Some factors may have more
influence than others. Perhaps significant changes due to
posture predominate in some patients. Testing vein diam-
eter differences with the patient supine and standing is a
simple procedure to identify patients prone to venodilata-
tion. This simple test, however, may not be sufficient to
describe the full range between minimal and maximum vein
diameters. In practice, some patients may have no reflux
while standing in the morning, yet reflux may be detected
when the test is repeated in the afternoon. Such cases
emphasize that venous dilatation beyond change in posture
must be considered, particularly if the patient has venous
symptoms and the morning test yields normal results. It is
beyond the scope of this work to discuss treatment options,
but factors other than postural change affect vein diameter
significantly and should not be ignored during appropriate
vein sizing for an endoprosthesis.
In summary, femoropopliteal veins present significant
variation in diameter that should be considered in planning
endovascular prosthetic venous valve implantation. In par-
Fig 3. Percentage of veins dilating 0 to less than 2 mm, 2 to less than 4 mm, and 4 mm or more. CFV, Common
femoral vein; PFV, proximal femoral vein; MFV, mid-femoral vein; DFV, distal femoral vein; PV, popliteal vein.
JOURNAL OF VASCULAR SURGERY
Volume 37, Number 5 Salles-Cunha et al 989
ticular, a subgroup of patients may have the capability of
significant dilatation to greater than 4 mm. These patients
should be identified before therapy. Further research is
warranted to determine whether large vein diameter vari-
ability may affect results of endovascular valve treatment.
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DISCUSSION
Dr Hugh Beebe (Perrysburg, Ohio). At the Jobst Vascular
Center, we have participated in phase I trials of a bovine bicuspid valve
and a surgically implanted bovine monocusp valve. Our results were
satisfactory and are in review for publication of a total experience of 5
patients. European investigators using the same devices did not have
satisfactory results. The trial has been interrupted. The primary reason
for interrupting the trial was to add improvements to the technology.
Dr John Corson (Iowa City, Iowa). How is this information
going to affect the selection of the diameter of the vein valve?
Dr Sergio Salles-Cunha. In the patients with mild and mod-
erate chronic valvular insufficiency, if you change the diameter and
the conditions and you do the reflux test, you will detect reflux
under conditions of vasodilatation and you will not detect reflux
under conditions of vasoconstriction in several of those patients. If
clinically you suspect valvular insufficiency and the test in the
vascular laboratory is normal in the morning, I recommend that
the patients be tested in the afternoon or in conditions of vasodi-
latation.
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